General Info
Host: | Rabbit |
Applications: | WB/IHC/IF/ELISA |
Reactivity: | Human/Mouse |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: | Rabbit polyclonal antibody anti-Cyclin-dependent kinase 8 (1-50 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: | Polyclonal |
Conjugation: | Unconjugated |
Isotype: | IgG |
Formulation: | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: | 1 mg/mL |
Dilution Range: | WB 1:500-1:2000IHC 1:100-1:300ELISA 1:10000IF 1:50-200 |
Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Information
Gene Symbol: | CDK8 |
Gene ID: | 1024 |
Uniprot ID: | CDK8_HUMAN |
Immunogen Region: | 1-50 aa |
Specificity: | Cdk8 Polyclonal Antibody detects endogenous levels of Cdk8 protein. |
Immunogen: | The antiserum was produced against synthesized peptide derived from the human CDK8 at the amino acid range 1-50 |
Description
Protein Name | Cyclin-Dependent Kinase 8Cell Division Protein Kinase 8Mediator Complex Subunit Cdk8Mediator Of Rna Polymerase Ii Transcription Subunit Cdk8Protein Kinase K35 |
Database Links | Reactome: R-HSA-1989781Reactome: R-HSA-2122947Reactome: R-HSA-212436Reactome: R-HSA-2173796Reactome: R-HSA-2644606Reactome: R-HSA-2894862Reactome: R-HSA-381340 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Cyclin-Dependent Kinase 8 antibodyAnti-Cell Division Protein Kinase 8 antibodyAnti-Mediator Complex Subunit Cdk8 antibodyAnti-Mediator Of Rna Polymerase Ii Transcription Subunit Cdk8 antibodyAnti-Protein Kinase K35 antibodyAnti-CDK8 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance